Ouster Stock Surges on New Drone Interceptor Partnership Announcement Qualcomm Gains Momentum as Investor Sentiment Shifts Toward AI Device Boom US Prioritizes AI Integration in Asia Following TrumpXi Engagement US Natural Gas Futures Decline as Warmer Weather Forecasts Reduce Heating Demand AI Infrastructure and Energy Stocks Outperform Nvidia A New Investment Frontier Tech Hiring Faces Headwinds as Employers Navigate Economic and Policy Uncertainty CompTIA Analysis Finds SOC Q1 2026 Earnings EPS Misses Estimates by Wide Margin No Revenue Reported IPHA Q1 2026 Earnings EPS Misses Estimates Significantly Yet Stock Rises AMP Q1 2026 Earnings EPS Beats Estimates by 923 as Wealth Management Segment Drives Results Danaher Corporation DHR Q1 2026 Earnings EPS Beats Estimates by 531 Amid Mixed Disclosures M Q1 2026 Earnings EPS Beats Estimates by 67 Amidst Ongoing Transformation RES Q1 2026 Earnings EPS Beats Estimates by 1858 Amid Broader Market Headwinds Flagstar Bank FLG Edges Higher as Support Holds Near 1333 Watsco Inc WSO Extends Gains Approaching Key Resistance Zone Lineage Inc LINE Finds Support Climbs 2 Can Momentum Persist Radiopharm Theranostics RADX Edges Higher Amid Sector Interest Key Levels to Watch Home Federal Bancorp HFBL Surges 313 as Price Approaches Key Resistance Level Stellantis Restructuring Prediction Market Oversight Oura IPO Lead Morning Market Briefing Seven Hills Realty Trust SEVN Q1 2026 Earnings Narrow EPS Beat Fails to Lift Stock as Market Stays Cautious Kiniksa Pharmaceuticals KNSA Slips 193 as Stock Tests 52 Level BSBR Q1 2023 Earnings Significant EPS Miss Sends Stock Lower SQM Q2 2025 Earnings Lithium Tailwinds Lift Profitability Amid Market Recovery Teads Holding Co TEAD Q1 2026 Earnings EPS Beats Expectations by 257 Amid Challenging Ad Market Stock Slips APD Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Execution Kyntra Bio Inc KYNB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as Stock Edges Higher SLRC Q1 2026 Earnings Investment Income Misses Expectations as Stock Declines Contineum Therapeutics Inc CTNM Q1 2026 Earnings Narrower Loss Beats Expectations